Current Portfolio
Mabtech
A Swedish biotech company developing immunoassays for life science research.
Since 1986, Mabtech’s mission has been to aid research by providing the global scientific community with innovative tools. To that end, the company generates and produces a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications.
Key Facts
- Sector
Biotech
- Country
Sweden
- Fund
EQT Ventures III
- Entry
2024
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.